F.D.A. Seeks Restrictions on Teens’ Access to Flavored E-Cigarettes and a Ban on Menthol Cigarettes

The Food and Drug Administration on Thursday announced a series of restrictions aimed at combating a growing public health menace — flavored e-cigarettes and tobacco products that have lured young people into vaping and smoking. And in a bold regulatory move, the agency said it would move to outlaw two traditional tobacco products that disproportionately… Read More »

Variety of healthcare entities see a bright future for AI

A survey of 500 senior healthcare executives by Optum reveals optimism on the promise of artificial intelligence, offset by the work needed to achieve results. Participating vice presidents and C-level executives that included CEO, COO, CFO, CTO and CMOs represented hospitals, clinics and delivery systems, life sciences organizations, health insurers and employers. Nearly all the… Read More »

AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win

AbbVie’s Orilissa (elagolix) snagged its first FDA approval over the summer, and now it’s looking to make it two. On Wednesday, the Illinois drugmaker and partner Neurocrine Biosciences unveiled details from a pair of phase 3 studies showing that the drug—already approved as a treatment for endometriosis-related pain—had topped placebo at reducing heavy menstrual bleeding… Read More »